SSX2IP and liver cancer: There are several reasons for the poor treatment outcomes in patients with advanced liver cancer, including the natural drug resistance of liver cancer cells and the high expression of various proteins, such as P-glycoprotein and SSX2IP, which promote drug resistance [8, 9].